CLEO Diagnostics kicks off ovarian cancer-detecting blood test trials in USA
Cleo Diagnostics (ASX:COV) has revealed it's kicked off US-based trials sussing the reliability of its blood tests designed to detect ovarian cancer.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results